All Government articles – Page 26
-
OpinionFive citizen science projects receive funding from UKRI
The projects cover a range of topics including mental health and microplastics
-
NewsSwiss decision to abandon trade talks raises questions over research relationship with EU
Political fallout could hit Swiss involvement in European science programmes
-
NewsCitizen initiative yields new parliamentary science office for Spain
New body will foster evidence-informed decision-making and awareness programmes for the public
-
BusinessAlzheimer’s antibody gets surprise US approval
Good news for industry and future drug approvals, but physicians doubt it will be effective for most patients
-
BusinessDeadly fire in Indian chemical factory
Blaze killed 18 workers, mainly women, who were trapped inside SVS Aqua Technologies plant
-
NewsAndrew Mackenzie selected as new UKRI chair
Shell’s company chair to lead UK’s largest research funding body
-
NewsHorizon Europe uncertainty and cuts to UKRI budget worries scientists
Autumn spending review will now be crucial in deciding whether UK hits R&D spending targets for 2024–25
-
NewsLeader sought for UK’s blue skies science funding body
Risk takers wanted to lead UK’s agency modelled on the US’s Darpa
-
NewsEnvironment agency overturns contentious Trump-era ‘secret science’ rule
Directive finalised at the end of Trump’s presidency would have hindered use of non-public data in policymaking
-
OpinionA sustainable legacy
President of the RSC, Tom Welton, asks what kind of chemical legacy we are leaving for the future
-
NewsScientists build case for a UK x-ray laser more advanced than any in the world
Support sought for facility with higher quality, shorter pulses, to begin operation after 2030
-
BusinessStriving to bolster the antibiotic pipeline before it becomes the next crisis
It’s been almost 10 years since the world was warned of a post-antibiotic apocalypse. Katrina Megget takes a look at the initiatives trying to support antimicrobial R&D
-
BusinessUS supreme court ends Sandoz–Amgen biosimilar dispute
Sandoz’s copy of arthritis drug Enbrel won’t be available in the US until 2029, 30 years after it was first marketed
-
NewsUS professor with China ties jailed for lying on grant applications
Ex-Ohio State researcher sentenced to 37 months in prison and must pay $3.4 million back to a federal agency
-
NewsPromotion of Covid-19 pseudoscience by Indian government criticised as pandemic rages
Questionable therapies under study or promoted include prayer, breathing exercises and herbal medicines
-
NewsReport finds reasons for optimism and room for improvement in French science
Assessment reveals weaknesses in chemistry
-
BusinessWhat might UK Reach look like?
As the UK’s legal system finds its feet post-Brexit, stakeholders have mixed feelings about the changes it could bring
-
NewsUS onboard with effort to waive global Covid-19 vaccine patents
Biden administration says pandemic calls for ‘extraordinary measures’ to relinquish IP protections, but pharma and biotech sectors push back
-
NewsUS chemical industry spent $61M to fend off PFAS regulations
Campaign finance records show how chemicals producers lobby against policies aimed to regulate persistent PFAS pollutants
-
BusinessCoca-Cola chemist convicted of trade secret theft
Xiaorong You stole files detailing BPA-free can coatings from seven major chemicals firms